-
Symbol
-
MPLT on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
19.7M shares
-
Security Ownership
-
45.1%
Catalyst4, Inc. ownership in MapLight Therapeutics, Inc. Common Stock, $0.0001 par value per share (MPLT)
2025-11-20 - Catalyst4, Inc. has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 19.7M shares of MapLight Therapeutics, Inc. Common Stock, $0.0001 par value per share (MPLT).
This represents 45.1% percent ownership of the company.